Macrophage apoptosis plays a determinant role in progression of atherosclerotic lesions. An important goal in atherosclerosis research is to identify new components of macrophage apoptosis that can eventually be exploited as molecular targets in strategies aimed at manipulating macrophage function in the lesion. In the previous work from our laboratory, we have shown that transient receptor potential canonical 3 (TRPC3) channel is an obligatory component of survival mechanisms in human and murine macrophages and that TRPC3-deficient non-polarized bone marrow-derived macrophages exhibit increased apoptosis, suggesting that in vivo TRPC3 might influence lesion development. In the present work, we used a bone marrow transplantation strategy as a first approach to examine the impact of macrophage deficiency of TRPC3 on early and advanced atherosclerotic lesions of Apoe 2/2 mice.
Introduction
In atherosclerosis, macrophage apoptosis is fundamental in determining plaque progression. At early stages, macrophage apoptosis combined with efficient clearance of apoptotic cells-efferocytosishelps in maintaining reduced cellularity and slows lesion progression 1, 2 In advanced plaques, however, when efferocytosis is impaired, accumulation of apoptotic cells contributes to enlargement of necrotic areas and plaque instability, the preamble of acute coronary syndromes. 2, 3 Thus, identifying signalling components associated with those mechanisms is of importance to pinpoint candidate targets for molecular or pharmacological manipulation of macrophage function in the lesion.
The previous work from our laboratory showed that transient receptor potential canonical 3 (TRPC3), a member of the TRPC family of Ca 2+ -permeable channels, 4 is an obligatory component of survival mechanisms in human and murine macrophages. 5, 6 In those studies, we found that TRPC3-deficient, non-polarized bone marrow-derived macrophages (BMDMs) exhibit, in vitro, impaired survival signalling and increased apoptosis, suggesting that macrophage deficiency of TRPC3 would be influential in accumulation of lesional apoptotic cells and lesion development in the setting of atherosclerosis. 5 To address this, in the present work we used a bone marrow transplantation (BMT) strategy in which Apoe 2/2 mice were transplanted with bone marrow from Trpc3 2/2 Apoe 2/2 or Trpc3 +/+ Apoe 2/2 animals and lesions were analysed at early and advanced stages of development.
After 3 weeks of high-fat diet mice that received TRPC3-deficient bone marrow had smaller lesions with less macrophage than the control group. Contrarily, advanced lesions from these mice showed a reduction in apoptotic cell accumulation and necrosis with an increase in collagen content and cap thickness. In contrast to our previous in vitro observations on non-polarized macrophages, 5 TRPC3-deficient macrophages polarized to the M1 phenotype showed reduced apoptosis, whereas both M1 and M2 macrophages exhibited increased efferocytic capacity. Our findings indicate that bone marrow deficiency of TRPC3 has a dual beneficial effect on lesion progression by reducing cellularity at early stages and necrosis in the advanced plaques. This represents the first evidence indicating a role of a member of the TRPC family of channelforming proteins in mechanisms associated with atherosclerotic lesion formation.
Methods

Bone marrow transplantation (BMT)
Animal studies conform to the Guide for the Care 
Aortic root sectioning
Aortic root sectioning, immunohistochemistry and lesion analysis were performed as described in Smedlund et al. 7 and in Supplementary material online.
Preparation of BMDMs
BMDMs were obtained as described in Tano et al. 5 (see Supplementary material online). The evaluation of apoptosis and immunoblotting of whole-cell proteins from BMDMs were as we described in Tano et al. 
Statistical analysis
Values are shown as means + SEM. Comparisons between groups were performed by the Mann-Whitney U test using Prism Graph Pad version 6 for Windows 2007 (San Diego, CA). P-values .0.05 were considered significant.
Results
We generated ApoE 2/2 mice with bone marrow deficiency of TRPC3
by means of BMT as a first approach to examine the impact of macrophage TRPC3 deficiency on atherosclerotic lesion characteristics. Figure S1 ). At sacrifice, body weight, plasma cholesterol, triglycerides, and lipoprotein profiles were examined, parameters which did not show significant differences between groups at either diet period (Supplementary material online, Table I and Figure S2 ). After 3 weeks of diet morphometric analysis of aortic root lesions showed a reduction in the total lesion area and neutral lipid content in Trpc3 online, Figure S1D ). As shown previously by others, 3,9 feeding transplanted Apoe 2/2 mice with high-fat diet during 8 weeks was sufficient to induce advanced lesions in the proximal aorta. At this time, the total lesion size and the neutral lipid content were not different between groups (Figure 2 ), neither was macrophage content (see Supplementary material online, Figure S3 ). However, advanced lesions from Trpc3 2/2 Apoe 2/2 mice showed a reduction of 40% in the necrotic core area (138 273 + 22 595 mm 2 compared with 232 300 + 33 440 mm 2 in control mice; P ¼ 0.03; Figure 3 ), corresponding to a Figure 3B ), larger fibrous cap thickness ( 35%, P ¼ 0.001; Figure 3C ; see also Supplementary material online, Figure S4 ), and higher cap/ core ratio (0. Apoe 2/2 mice showed a two-fold reduction in the number of apoptotic cells compared with controls ( Figure 4A ) and this correlated with a reduced number of apoptotic cells that co-localized with macrophages ( Figure 4B ).
In a recent study, we found that Trpc3 2/2 non-polarized BMDMs were more susceptible to apoptosis than Trpc3 +/+ cells. 5 Besides the nonpolarized, a number of macrophage phenotypes can be found in lesions among which the M1 and M2 classes are well characterized. 13 mice and induced them to differentiate in vitro into M1 and M2 types. TRPC3 deficiency did not affect the expression of specific M1 and M2 markers (see Supplementary material online, Figure S6A and B). In addition, the expression of SRA, CD36, or TLR-4 was comparable between Trpc3 +/+ and Trpc3 2/2 cells both at mRNA and protein levels (see Supplementary material online, Figure S6C -E). BMDMs were serum starved or treated with oxLDL (50 mg/mL) or the endoplasmic reticulum (ER) stressor thapsigargin (1 mM) for 24 h and apoptosis was evaluated by the in vitro TUNEL assay. Whereas TRPC3 deficiency did not affect apoptosis of M2 macrophages (not shown), apoptosis induced by serum starvation, oxLDL, or thapsigargin was reduced in M1-Trpc3 2/2 Apoe 2/2 macrophages compared with controls ( Figure 5A) Figure S7 ). Using iNOS as an M1 marker and its co-localization with macrophage staining, significant M1 immunoreactivity was observed in advanced lesions from Trpc3 +/+ Apoe 2/2 and Trpc3
Apoe 2/2 mice, whereas it was either minimal or not present in early lesions from both groups of animals (see Supplementary material online, Figure S8 ). By means of an in vitro efferocytosis assay, we also examined the effect of TRPC3 deficiency on the efferocytic capacity of M1 and M2 BMDMs ( Figure 5B) . Remarkably, M1-Trpc3 2/2 Apoe 2/2 and M2-Trpc3
Apoe 2/2 phagocytes exhibited higher efferocytic capacity than corresponding controls. mRNA levels of LRP-1 and MERTK, both recognized to influence efferocytosis, 2, 9 were similar regardless of the TRPC3 expression status; however, protein levels of MERTK were 60% higher (after background subtraction and normalizing by GAPDH) in TRPC3-deficient macrophages compared with control cells (see Supplementary material online, Figure S6E ).
Discussion
The present studies were aimed at examining the impact of bone marrow deficiency of TRPC3 on the characteristics of atherosclerotic lesions in the aortic sinus of Apoe 2/2 mice. A number of salient findings were made. Bone marrow deficiency of TRPC3 resulted in a beneficial effect on early stages, evidenced by a reduction in size and cellularity of lesions in mice maintained on a 3-week high-fat diet. In advanced lesions, bone marrow deficiency of TRPC3 was associated with reduced necrosis, increased collagen content, and increased cap thickness. Compared with control animals, advanced plaques from mice with Trpc3 2/2 bone marrow had a reduced number of apoptotic macrophages.
As reported previously by others, 3, 16 our studies also show that the reduced necrosis in advanced plaques can occur in the absence of changes in lipid and macrophage content. This is not surprising considering that necrotic cores are rich in free cholesterol, a poor substrate for Oil-Red-O 12 and that the macrophage antibody used also stains prenecrotic macrophages, rendering the resultant staining independent of necrosis content. Also, the reduced necrosis in lesions from Trpc3
Apoe 2/2 mice was not paralleled by changes in the total lesion area.
These findings support the notion put forward by Manning-Tobin et al. 17 that necrosis results from a number of events occurring over the entire timeline of the experimental studies and reflects the integrated effect of macrophage apoptosis, deficient efferocytosis, and bidirectional trafficking of macrophages through the intima, not necessarily paralleling lesion growth. The pool of lesional macrophages consists of a number of phenotypes which includes non-polarized and the polarized M1 and M2 types. 13, 18 Studies in human and murine lesions indicate that as lesion progresses M1 macrophages become dominant. 13, 19, 20 The in vitro results obtained here with Trpc3 +/+ Apoe 2/2 and Trpc3 2/2 Apoe 2/2 BMDMs differentiated to M1 and M2 phenotypes indicate that TRPC3 deficiency has quite opposite effects in polarized macrophages compared with our previous observations on non-polarized cells. 5 While TRPC3 deficiency increases apoptosis of non-polarized BMDMs, 5 TRPC3-deficient M1, but not M2 macrophages, exhibited reduced susceptibility to atherorelevant pro-apoptotic stimuli. Activated CAMKII and STAT1 are key mediators of ER stress-induced apoptosis in non-polarized macrophages from murine and human origin. 15 Our findings in TRPC3-deficient M1
macrophages showing a correlation between reduced apoptosis and impaired activation of CAMKII and STAT1 suggest that also in polarized cells CAMKII and STAT1 seem associated with ER stress-induced apoptosis, in line with the proposed universality of these pathways in macrophages. 15 Furthermore, our data suggest that TRPC3 expression and/or constitutive function is required, to some extent, for proper operation of these signalling pathways. In addition, M1 and M2 Trpc3 At early stages, macrophage apoptosis is coupled to efficient efferocytosis, which explains the common observation that apoptotic cells in early lesions are found in very low numbers or none at all. 1, 12 In agreement with this, our in situ TUNEL staining showed that after 3 weeks of diet apoptotic cells were a rare find in both groups of animals. Considering our previous findings that TRPC3 deficiency increases apoptosis of non-polarized macrophages and that a significant proportion of macrophages in early lesions of Apoe 2/2 mice are non-polarized cells, 13 it is probable that at this time point increased apoptotic rates of Trpc3
non-polarized cells contributed to the reduced plaque cellularity and size observed in these mice. The present studies illustrate the not rare observation that signalling proteins involved in macrophage apoptosis can differentially affect lesion characteristics depending upon lesion stage and underscore the importance of changes in relative abundance of macrophage phenotypes throughout lesion development in determining the actual impact of a particular signalling protein on plaque characteristics through macrophage apoptosis.
A great deal of experimental evidence has accumulated documenting the participation of TRPCs in the pathogenesis of cardiovascular diseases (reviewed by us in Tano et al. 25 and Abramowitz and Birnbaumer 26 ). TRPC3, in particular, has been implicated in essential hypertension, cardiac hypertrophy, and endothelial dysfunction, but its potential role in atherosclerosis has remained largely unexplored. As of this writing, there is no evidence for a role of TRPC3 in murine or human atherosclerosis. Despite the existence of several single nucleotide polymorphisms in the human Trpc3 gene, clinically associated human variations have not been reported. Interestingly, in expression profile studies using human genomic microarrays Trpc3 mRNA appears up-regulated in plaques from patients with atherosclerotic lesions in the left anterior descendent coronary artery. 27 The present work thus pioneers the field by providing for the first time experimental evidence underscoring a potential role of TRPC3 at both early and advanced stages of lesion development.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
Conflict of interest: none declared. TRPC3 and atherosclerosis
